Iberdomide vs. Observation Post Ide-Cel CAR-T

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Near Add Your Location

Sorting 76 by

Huntsman Cancer Institute
University of Utah
Salt Lake City, UT
  • Not currently accepting
Atrium Health's Levine Cancer Institute - Charlotte (Main)
Atrium Health
Charlotte, NC
  • Not currently accepting
Aurora Cancer Care
Aurora St. Luke's Medical Center
Milwaukee, WI
  • Not currently accepting
Memorial Sloan Kettering Cancer Center
New York, NY
  • Not currently accepting
  • Show Principal Investigator
Fred Hutchinson Cancer Research Center
University of Washington Cancer Consortium / SCCA
Seattle, WA
  • Not currently accepting
University of Nebraska Medical Center
Fred & Pamela Buffett Cancer Center
Omaha, NE
  • Not currently accepting
  • Show Principal Investigator
Memorial Sloan Kettering Bergen
Montvale, NJ
  • Not currently accepting
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Not currently accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.